
Cardiff Oncology Inc
CRDFNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$1.87
Day High
$1.91
Day Low
$1.82
Prev. Close
$1.84
VolumeShares traded today.
766.32K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$129.90M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-2.86
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$4.56
52W LowLowest price over the past 52 weeks.
$1.48
50D MAAverage closing price over the last 50 trading days.
$1.69
200D MAAverage closing price over the last 200 trading days.
$2.08
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+6.1%1M
+17.3%6M
-10.0%YTD
-28.6%1Y
-43.3%About
Peter Elliott is a British pharmacologist and drug developer who has initiated clinical trials across a range of disease areas, and is the co-developer of Velcade, a drug used to treat multiple myeloma.
cardiffoncology.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade CRDF
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.